Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Translation and cultural adaptation of the King's Brief Interstitial Lung Disease health status questionnaire for use in Brazil.

Silveira K, Steidle LJM, Matte DL, Tavares PH, Pincelli MP, Pizzichini MMM, Pizzichini E, Birringer SS, Tavares MGS.

J Bras Pneumol. 2019 Sep 16;45(5):e20180194. doi: 10.1590/1806-3713/e20180194. English, Portuguese.

2.

Prescribing trends in and perceptions of the treatment of asthma: a survey among pulmonologists in Brazil.

Cançado JED, Athanazio RA, Cunha LFR, Pizzichini MMM.

J Bras Pneumol. 2019 Jul 29;45(5):e20190083. doi: 10.1590/1806-3713/e20190083. English, Portuguese. No abstract available.

3.

Celebrating World Asthma Day in Brazil: is the glass half full or half empty?

Pizzichini MMM, Cruz ÁA.

J Bras Pneumol. 2019 May 30;45(3):e20190130. doi: 10.1590/1806-3713/e20190130. English, Portuguese. No abstract available.

4.

Prevalence of smoking and reasons for continuing to smoke: a population-based study.

Rocha SAV, Hoepers ATC, Fröde TS, Steidle LJM, Pizzichini E, Pizzichini MMM.

J Bras Pneumol. 2019 Mar 28;45(4):e20170080. doi: 10.1590/1806-3713/e20170080. English, Portuguese.

5.

How does the GINA definition of control correlate with quality of life and sputum cellularity?

Pizzichini MMM, Rocha CC, de Souza Tavares MG, Steidle LJM, Maureci da Silva R, Dal Pizzol F, Gibson PG, Pizzichini E.

ERJ Open Res. 2019 Feb 4;5(1). pii: 00146-2018. doi: 10.1183/23120541.00146-2018. eCollection 2019 Feb.

6.

IL-5 Levels in Nasosorption and Sputosorption Correlate with Sputum Eosinophilia in Allergic Asthma.

Melo JT Jr, Tunstall T, Pizzichini MMM, Maurici R, Rocha CC, Dal-Pizzol F, Gonçalves J, Hansel TT, Thwaites RS, Pizzichini E.

Am J Respir Crit Care Med. 2019 Jan 15;199(2):240-243. doi: 10.1164/rccm.201807-1279LE. No abstract available.

7.

Rhinosinusitis symptoms, smoking and COPD: Prevalence and associations.

Caminha GP, Pizzichini E, Lubianca Neto JF, Hopkins C, Moreira JDS, Pizzichini MMM.

Clin Otolaryngol. 2018 Dec;43(6):1560-1565. doi: 10.1111/coa.13215. Epub 2018 Sep 19.

PMID:
30152142
8.

Is the COPD Assessment Test sensitive for differentiating COPD patients from active smokers and nonsmokers without lung function impairment? A population-based study.

Karloh M, Rocha SAV, Pizzichini MMM, Cavalli F, Matte DL, Pizzichini E; Respira Floripa Group.

J Bras Pneumol. 2018 May-Jun;44(3):213-219. doi: 10.1590/S1806-37562017000000149. English, Portuguese.

9.

Translation and cultural adaptation of a specific instrument for measuring asthma control and asthma status: the Asthma Control and Communication Instrument.

Tavares MGS, Brümmer CF, Nicolau GV, Melo JT Jr, Nazário NO, Steidle LJM, Patino CM, Pizzichini MMM, Pizzichini E.

J Bras Pneumol. 2017 Jul-Aug;43(4):264-269. doi: 10.1590/S1806-37562016000000182. English, Portuguese.

10.

The Quebec Sleep Questionnaire on quality of life in patients with obstructive sleep apnea: translation into Portuguese and cross-cultural adaptation for use in Brazil.

Melo JT Júnior, Maurici R, Tavares MGS, Pizzichini MMM, Pizzichini E.

J Bras Pneumol. 2017 Sep-Oct;43(5):331-336. doi: 10.1590/S1806-37562016000000160. Epub 2017 Jul 31. English, Portuguese.

11.

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study.

Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Martin RJ, Pizzichini E, Pizzichini MMM, Burden A, Martin J, Price DB.

Clin Epidemiol. 2017 Apr 26;9:231-243. doi: 10.2147/CLEP.S127775. eCollection 2017.

12.

Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies.

Matte DL, Pizzichini MM, Hoepers AT, Diaz AP, Karloh M, Dias M, Pizzichini E.

Respir Med. 2016 Aug;117:154-61. doi: 10.1016/j.rmed.2016.06.006. Epub 2016 Jun 7. Review.

13.

Temporal trends in the prevalence of asthma and rhinoconjunctivitis in adolescents.

Wilmer FA, Maurici R, Nazário CA, Nazário KC, Pássaro PF, Piazza HE, Bertoldi RA, Pizzichini E, Pizzichini MM.

Rev Saude Publica. 2015;49. pii: S0034-89102015000100272. doi: 10.1590/S0034-8910.2015049005558. Epub 2015 Dec 31. English, Portuguese.

14.

Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice.

Pizzichini MM, Kerstjens HA, Pizzichini E.

Pol Arch Med Wewn. 2015;125(11):859-66. Epub 2015 Oct 30. Review. Erratum in: Pol Arch Med Wewn. 2015;125(12):954.

15.

The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages.

Karloh M, Fleig Mayer A, Maurici R, Pizzichini MMM, Jones PW, Pizzichini E.

Chest. 2016 Feb;149(2):413-425. doi: 10.1378/chest.15-1752. Epub 2016 Jan 12. Review.

PMID:
26513112
16.

Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma.

Schwingel FL, Pizzichini E, Kleveston T, Morato EF, Pinheiro JT, Steidle LJ, Dal-Pizzol F, Rocha CC, Pizzichini MM.

Ann Allergy Asthma Immunol. 2015 Dec;115(6):485-9. doi: 10.1016/j.anai.2015.10.003. Epub 2015 Oct 24.

PMID:
26508705
17.

Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis.

Sakae TM, Maurici R, Trevisol DJ, Pizzichini MM, Pizzichini E.

J Bras Pneumol. 2014 Oct;40(5):552-63. Review. English, Portuguese.

18.

Reliability of a rapid hematology stain for sputum cytology.

Gonçalves J, Pizzichini E, Pizzichini MM, Steidle LJ, Rocha CC, Ferreira SC, Zimmermann CT.

J Bras Pneumol. 2014 May-Jun;40(3):250-8. English, Portuguese.

19.

Leicester Cough Questionnaire: translation to Portuguese and cross-cultural adaptation for use in Brazil.

Felisbino MB, Steidle LJ, Gonçalves-Tavares M, Pizzichini MM, Pizzichini E.

J Bras Pneumol. 2014 May-Jun;40(3):213-21. English, Portuguese.

20.

Update on etiopathogenesis of systemic sclerosis.

Zimmermann AF, Pizzichini MM.

Rev Bras Reumatol. 2013 Nov-Dec;53(6):516-24. doi: 10.1016/j.rbr.2013.01.001. Review. English, Portuguese.

21.

Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis.

Sakae TM, Pizzichini MM, Teixeira PJ, Silva RM, Trevisol DJ, Pizzichini E.

J Bras Pneumol. 2013 May-Jun;39(3):259-71. doi: 10.1590/S1806-37132013000300002. Review. English, Portuguese.

22.

SNOT-22: psychometric properties and cross-cultural adaptation into the Portuguese language spoken in Brazil.

Caminha GP, Melo Junior JT, Hopkins C, Pizzichini E, Pizzichini MM.

Braz J Otorhinolaryngol. 2012 Dec;78(6):34-9.

23.
24.

Gastroesophageal reflux disease and airway hyperresponsiveness: concomitance beyond the realm of chance?

Ratier JC, Pizzichini E, Pizzichini M.

J Bras Pneumol. 2011 Sep-Oct;37(5):680-8. Review. English, Portuguese.

25.

Sputum induction in severe exacerbations of asthma: safety of a modified method.

Vieira MO, Pizzichini E, Steidle LJ, da Silva JK, Pizzichini MM.

Eur Respir J. 2011 Oct;38(4):979-80. doi: 10.1183/09031936.00029511. No abstract available.

26.

Cellular composition of induced sputum in healthy adults.

Veras TN, Pizzichini E, Steidle LJ, Rocha CC, Moritz P, Pizzichini MM.

J Bras Pneumol. 2011 May-Jun;37(3):348-53. English, Portuguese.

27.

The Asthma Control Scoring System: translation and cross-cultural adaptation for use in Brazil.

Tavares MG, Pizzichini MM, Steidle LJ, Nazário NO, Rocha CC, Perraro MC, Pizzichini E.

J Bras Pneumol. 2010 Nov-Dec;36(6):683-92. English, Portuguese.

28.

Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities.

Wang HY, Pizzichini MM, Becker AB, Duncan JM, Ferguson AC, Greene JM, Rennie DC, Senthilselvan A, Taylor BW, Sears MR.

Pediatr Allergy Immunol. 2010 Aug;21(5):867-77. doi: 10.1111/j.1399-3038.2010.01064.x. Epub 2010 May 11.

PMID:
20492543
29.

[Prevalence of asthma symptoms and risk factors among adolescents in Tubarão and Capivari de Baixo, Santa Catarina State, Brazil].

Breda D, Freitas PF, Pizzichini E, Agostinho FR, Pizzichini MM.

Cad Saude Publica. 2009 Nov;25(11):2497-506. Portuguese.

30.

Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study.

Chakir J, Loubaki L, Laviolette M, Milot J, Biardel S, Jayaram L, Pizzichini M, Pizzichini E, Hargreave FE, Nair P, Boulet LP.

Eur Respir J. 2010 Jan;35(1):48-53. doi: 10.1183/09031936.00130008. Epub 2009 Jul 16.

31.

Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children.

Drews AC, Pizzichini MM, Pizzichini E, Pereira MU, Pitrez PM, Jones MH, Sly PD, Stein RT.

Allergy. 2009 Nov;64(11):1597-601. doi: 10.1111/j.1398-9995.2009.02057.x. Epub 2009 Apr 14.

PMID:
19392986
32.

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.

N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.

33.

Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice.

Moritz P, Steidle LJ, Felisbino MB, Kleveston T, Pizzichini MM, Pizzichini E.

J Bras Pneumol. 2008 Nov;34(11):913-21. English, Portuguese.

34.

Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease.

Wilson AM, Leigh R, Hargreave FE, Pizzichini MM, Pizzichini E.

COPD. 2006 Jun;3(2):89-93.

PMID:
17175671
35.

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemière C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE.

Eur Respir J. 2006 Mar;27(3):483-94.

36.

Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.

Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E.

Eur Respir J. 2006 May;27(5):964-71. Epub 2006 Jan 30.

37.

Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.

Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE, Pizzichini MM.

Thorax. 2005 Feb;60(2):100-5.

38.

Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.

Jayaram L, Duong M, Pizzichini MM, Pizzichini E, Kamada D, Efthimiadis A, Hargreave FE.

Eur Respir J. 2005 Jan;25(1):41-6.

39.

Is sputum eosinophilia a good or poor predictor of benefit from inhaled corticosteroid therapy in asthma?

Pizzichini MM.

Eur Respir J. 2002 Dec;20(6):1359-61. No abstract available.

40.

Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors.

Pizzichini M, Fonzi M, Giannerini F, Mencarelli M, Gasparoni A, Rocchi G, Kaitsas V, Fonzi L.

Sci Total Environ. 2003 Jan 1;301(1-3):43-50.

PMID:
12493183
41.

Safety of sputum induction.

Pizzichini E, Pizzichini MM, Leigh R, Djukanović R, Sterk PJ.

Eur Respir J Suppl. 2002 Sep;37:9s-18s. Review. No abstract available.

42.

The use of induced sputum in clinical trials.

Kips JC, Inman MD, Jayaram L, Bel EH, Parameswaran K, Pizzichini MM, Pavord ID, Djukanović R, Hargreave FE, Sterk PJ.

Eur Respir J Suppl. 2002 Sep;37:47s-50s. Review. No abstract available.

43.

Clinical applications of assessment of airway inflammation using induced sputum.

Pavord ID, Sterk PJ, Hargreave FE, Kips JC, Inman MD, Louis R, Pizzichini MM, Bel EH, Pin I, Grootendorst DC, Parameswaran K, Djukanović R.

Eur Respir J Suppl. 2002 Sep;37:40s-43s. Review. No abstract available.

44.

Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation.

Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djukanović R.

Eur Respir J Suppl. 2002 Sep;37:19s-23s. Review. No abstract available.

45.

Purine nucleotide catabolism in rat liver: labelling of uric acid and allantoin after administration of various labelled precursors.

Marinello E, Arezzini L, Pizzichini M, Frosi B, Porcelli B, Terzuoli L.

Life Sci. 2002 May 3;70(24):2931-41.

PMID:
12269403
46.

Release of mercury from dental amalgam and its influence on salivary antioxidant activity.

Pizzichini M, Fonzi M, Sugherini L, Fonzi L, Gasparoni A, Comporti M, Pompella A.

Sci Total Environ. 2002 Feb 4;284(1-3):19-25.

PMID:
11846163
47.

The mercury concentration in saliva: correlation to number and extension of dental amalgam restorations.

Fonzi L, Pizzichini M.

Bull Group Int Rech Sci Stomatol Odontol. 1999 Apr-Sep;41(2-3):57. No abstract available.

PMID:
11799744
48.

Release of mercury from dental amalgam and its influence on salivary antioxidant activity.

Pizzichini M, Fonzi M, Sugherini L, Fonzi L, Comporti M, Gasparoni A, Pompella A.

Bull Group Int Rech Sci Stomatol Odontol. 2000 May-Dec;42(2-3):94-100.

PMID:
11799733
49.

Salivary mercury levels in healthy donors with and without amalgam fillings.

Pizzichini M, Fonzi M, Gasparoni A, Fonzi L.

Bull Group Int Rech Sci Stomatol Odontol. 2000 May-Dec;42(2-3):88-93.

PMID:
11799732
50.

Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors.

Pizzichini M, Fonzi M, Gasparoni A, Mencarelli M, Rocchi G, Kaitsas V, Fonzi L.

Bull Group Int Rech Sci Stomatol Odontol. 2001 May-Sep;43(2):62-7.

PMID:
11799720

Supplemental Content

Loading ...
Support Center